Literature DB >> 29669191

Perspectives of Rheumatoid Arthritis Patients on Electronic Communication and Patient-Reported Outcome Data Collection: A Qualitative Study.

Iris Navarro-Millán1, Anne Zinski2, Sally Shurbaji2, Bernadette Johnson2, Liana Fraenkel3, James Willig2, Maria I Danila2, Huifeng Yun2, Jeffrey R Curtis2, Monika M Safford4.   

Abstract

OBJECTIVE: To identify the perspectives of patients with rheumatoid arthritis (RA) on electronic recording of between-visit disease activity and other patient-reported outcomes (PROs) and on sharing this information with health care providers or peers.
METHODS: Patients with RA were recruited to participate in focus groups from December 2014 to April 2015. The topic guide and analysis were based on the Andersen-Newman framework. Sessions were audiorecorded, transcribed, independently coded, and analyzed for themes.
RESULTS: Thirty-one patients participated in 7 focus groups. Their mean ± SD age was 51 ± 13.1 years, 94% were women, 52% were African American, 11% were Hispanic, and 37% were white. Three themes emerged: provider communication, information-seeking about RA, and social and peer support. Participants expressed a willingness to track disease activity data to share with health care providers electronically if providers would act on the information. Participants envisioned symptom tracking and information sharing as a mechanism to relay and obtain reliable information about RA. Participants were also interested in electronic communication between visits if it facilitated learning about symptom management and enhanced opportunities for social support among patients with RA.
CONCLUSION: Patients with RA may be amenable to electronic collection and sharing of PRO-type data between clinical encounters if it facilitates communication with health care providers and provides access to reliable information about RA. Providing patients with social support was important for enhancing PROs collection by helping them overcome barriers by using electronic devices and overcome reservations about the value of these data.
© 2018, American College of Rheumatology.

Entities:  

Mesh:

Year:  2019        PMID: 29669191      PMCID: PMC6388703          DOI: 10.1002/acr.23580

Source DB:  PubMed          Journal:  Arthritis Care Res (Hoboken)        ISSN: 2151-464X            Impact factor:   4.794


  18 in total

1.  Thresholds in disease activity for switching biologics in rheumatoid arthritis patients: experience from a large U.S. cohort.

Authors:  Jie Zhang; Ying Shan; George Reed; Joel Kremer; Jeffrey D Greenberg; Scott Baumgartner; Jeffrey R Curtis
Journal:  Arthritis Care Res (Hoboken)       Date:  2011-12       Impact factor: 4.794

Review 2.  2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis.

Authors:  Jasvinder A Singh; Daniel E Furst; Aseem Bharat; Jeffrey R Curtis; Arthur F Kavanaugh; Joel M Kremer; Larry W Moreland; James O'Dell; Kevin L Winthrop; Timothy Beukelman; S Louis Bridges; W Winn Chatham; Harold E Paulus; Maria Suarez-Almazor; Claire Bombardier; Maxime Dougados; Dinesh Khanna; Charles M King; Amye L Leong; Eric L Matteson; John T Schousboe; Eileen Moynihan; Karen S Kolba; Archana Jain; Elizabeth R Volkmann; Harsh Agrawal; Sangmee Bae; Amy S Mudano; Nivedita M Patkar; Kenneth G Saag
Journal:  Arthritis Care Res (Hoboken)       Date:  2012-05       Impact factor: 4.794

3.  Physical function improvements and relief from fatigue and pain are associated with increased productivity at work and at home in rheumatoid arthritis patients treated with certolizumab pegol.

Authors:  Johanna M Hazes; Peter Taylor; Vibeke Strand; Oana Purcaru; Geoffroy Coteur; Philip Mease
Journal:  Rheumatology (Oxford)       Date:  2010-06-14       Impact factor: 7.580

4.  Relative importance of doctor-reported outcomes vs patient-reported outcomes in DMARD intensification for rheumatoid arthritis: the DUO study.

Authors:  Maxime Dougados; Henri Nataf; Ghislaine Steinberg; Stéphanie Rouanet; Bruno Falissard
Journal:  Rheumatology (Oxford)       Date:  2012-10-25       Impact factor: 7.580

5.  High disease activity may not be sufficient to escalate care.

Authors:  Liana Fraenkel; Meaghan Cunningham
Journal:  Arthritis Care Res (Hoboken)       Date:  2014-02       Impact factor: 4.794

6.  Use of "spydergrams" to present and interpret SF-36 health-related quality of life data across rheumatic diseases.

Authors:  V Strand; B Crawford; J Singh; E Choy; J S Smolen; D Khanna
Journal:  Ann Rheum Dis       Date:  2009-12       Impact factor: 19.103

Review 7.  2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis.

Authors:  Jasvinder A Singh; Kenneth G Saag; S Louis Bridges; Elie A Akl; Raveendhara R Bannuru; Matthew C Sullivan; Elizaveta Vaysbrot; Christine McNaughton; Mikala Osani; Robert H Shmerling; Jeffrey R Curtis; Daniel E Furst; Deborah Parks; Arthur Kavanaugh; James O'Dell; Charles King; Amye Leong; Eric L Matteson; John T Schousboe; Barbara Drevlow; Seth Ginsberg; James Grober; E William St Clair; Elizabeth Tindall; Amy S Miller; Timothy McAlindon
Journal:  Arthritis Care Res (Hoboken)       Date:  2015-11-06       Impact factor: 4.794

8.  Agreement of Ocular Symptom Reporting Between Patient-Reported Outcomes and Medical Records.

Authors:  Nita G Valikodath; Paula Anne Newman-Casey; Paul P Lee; David C Musch; Leslie M Niziol; Maria A Woodward
Journal:  JAMA Ophthalmol       Date:  2017-03-01       Impact factor: 7.389

9.  Improvements in health-related quality of life after treatment with tocilizumab in patients with rheumatoid arthritis refractory to tumour necrosis factor inhibitors: results from the 24-week randomized controlled RADIATE study.

Authors:  Vibeke Strand; Gerd R Burmester; Sarika Ogale; Jenny Devenport; Ani John; Paul Emery
Journal:  Rheumatology (Oxford)       Date:  2012-06-28       Impact factor: 7.580

10.  Rapid and sustained improvements in health-related quality of life, fatigue, and other patient-reported outcomes in rheumatoid arthritis patients treated with certolizumab pegol plus methotrexate over 1 year: results from the RAPID 1 randomized controlled trial.

Authors:  Vibeke Strand; Philip Mease; Gerd R Burmester; Enkeleida Nikaï; Geoffroy Coteur; Ronald van Vollenhoven; Bernard Combe; Edward C Keystone; Arthur Kavanaugh
Journal:  Arthritis Res Ther       Date:  2009-11-12       Impact factor: 5.156

View more
  11 in total

Review 1.  Application of Andersen's behavioural model of health services use: a scoping review with a focus on qualitative health services research.

Authors:  Mareike Lederle; Jana Tempes; Eva M Bitzer
Journal:  BMJ Open       Date:  2021-05-05       Impact factor: 3.006

2.  Which patient reported outcome domains are important to the rheumatologists while assessing patients with rheumatoid arthritis?

Authors:  Aprajita Jagpal; Ronan O'Beirne; Melanie S Morris; Bernadette Johnson; James Willig; Huifeng Yun; Andrea L Cherrington; Liana Fraenkel; Jeffrey R Curtis; Monika M Safford; Iris Navarro-Millán
Journal:  BMC Rheumatol       Date:  2019-09-05

3.  Associations of Arthritis-Attributable Interference with Routine Life Activities: A Modifiable Source of Compromised Quality-of-Life.

Authors:  K A Theis; T J Brady; C G Helmick; L B Murphy; K E Barbour
Journal:  ACR Open Rheumatol       Date:  2019-08-06

4.  Remote Measurement in Rheumatoid Arthritis: Qualitative Analysis of Patient Perspectives.

Authors:  Katie M White; Alina Ivan; Ruth Williams; James B Galloway; Sam Norton; Faith Matcham
Journal:  JMIR Form Res       Date:  2021-03-09

Review 5.  [Telemedical care and IT-based systems in rheumatology].

Authors:  Rick McCutchan; Philipp Bosch
Journal:  Z Rheumatol       Date:  2021-10-07       Impact factor: 1.372

6.  Patients' experiences and perspectives of patient-reported outcome measures in clinical care: A systematic review and qualitative meta-synthesis.

Authors:  Liam Carfora; Ciara M Foley; Phillip Hagi-Diakou; Phillip J Lesty; Marianne L Sandstrom; Imogen Ramsey; Saravana Kumar
Journal:  PLoS One       Date:  2022-04-21       Impact factor: 3.752

Review 7.  Effectiveness of remote care interventions: a systematic review informing the 2022 EULAR Points to Consider for remote care in rheumatic and musculoskeletal diseases.

Authors:  Andréa Marques; Philipp Bosch; Annette de Thurah; Yvette Meissner; Louise Falzon; Chetan Mukhtyar; Johannes Wj Bijlsma; Christian Dejaco; Tanja A Stamm
Journal:  RMD Open       Date:  2022-05

8.  Acceptance, Usage, and Barriers of Electronic Patient-Reported Outcomes Among German Rheumatologists: Survey Study.

Authors:  Martin Krusche; Philipp Klemm; Manuel Grahammer; Johanna Mucke; Diana Vossen; Arnd Kleyer; Philipp Sewerin; Johannes Knitza
Journal:  JMIR Mhealth Uhealth       Date:  2020-07-20       Impact factor: 4.773

9.  Acceptance of Telerheumatology by Rheumatologists and General Practitioners in Germany: Nationwide Cross-sectional Survey Study.

Authors:  Felix Muehlensiepen; Johannes Knitza; Wenke Marquardt; Jennifer Engler; Axel Hueber; Martin Welcker
Journal:  J Med Internet Res       Date:  2021-03-29       Impact factor: 5.428

Review 10.  Future challenges in rheumatology - is telemedicine the solution?

Authors:  Annette de Thurah; Andrea Marques; Savia de Souza; Cynthia S Crowson; Elena Myasoedova
Journal:  Ther Adv Musculoskelet Dis       Date:  2022-03-17       Impact factor: 5.346

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.